_id
691726153c536f8df2316b35
Ticker
UNCY
Name
Unicycive Therapeutics Inc
Exchange
NASDAQ
Address
4300 El Camino Real, Los Altos, CA, United States, 94022
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://unicycive.com
Description
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb RZB 012 for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company also evaluates licensing of technologies and drugs for orphan diseases, other renal, liver, and other metabolic diseases affecting fibrosis and inflammation. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd to develop and commercialize oxylanthanum carbonate; Sphaera Pharma Pte. Ltd.; Syneos Health LLC to develop of UNI-494; Inotiv for preclinical trial and related services for oxylanthanum carbonate and UNI-494; Lee's Pharmaceutical (HK) Limited; and Lotus International Pte Ltd for the development, registration filing, and approval for oxylanthanum carbonate. The company was incorporated in 2016 and is based in Los Altos, California.
Last Close
6.41
Volume
12593
Current Price
6.23
Change
-2.808112324492975
Last Updated
2025-12-04T14:46:47.656Z
Image
https://logo.clearbit.com/unicycive.com
Ipo Date
2021-07-12T00:00:00.000Z
Market Cap
132601912
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.983875
Sentiment Sources
8
Rating
4.5714
Target Price
46.5238
Strong Buy
4
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
7342000
Operating Income
-7342000
Interest Expense
15000
Pretax Income
-6011000
Net Income
-6011000
Eps
-0.3327357080437072
Dividends Per Share
0
Shares Outstanding
21491396
Income Tax Expense
-
EBITDA
-5848000
Operating Margin
-
Total Other Income Expense Net
1331000
Cash
42695000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
50287000
Property Plant Equipment
324000
Total Assets
50611000
Payables
957000
Short Term Debt
265000
Long Term Debt
-
Total Liabilities
13131000
Equity
37480000
Depreciation
148000
Change In Working Capital
237000
Cash From Operations
-5962000
Capital Expenditures
2000
Cash From Investing
-2000
Cash From Financing
26332000
Net Change In Cash
20368000
PE
-
PB
3.002864820437567
ROE
-16.037886872998932
ROA
-11.87686471320464
FCF
-5964000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
7342000
Quarters > 0 > income Statement > operating Income
-7342000
Quarters > 0 > income Statement > interest Expense
15000
Quarters > 0 > income Statement > pretax Income
-6011000
Quarters > 0 > income Statement > net Income
-6011000
Quarters > 0 > income Statement > eps
-0.3327357080437072
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
18065389
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-5848000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1331000
Quarters > 0 > balance Sheet > cash
42695000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
50287000
Quarters > 0 > balance Sheet > property Plant Equipment
324000
Quarters > 0 > balance Sheet > total Assets
50611000
Quarters > 0 > balance Sheet > payables
957000
Quarters > 0 > balance Sheet > short Term Debt
265000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
13131000
Quarters > 0 > balance Sheet > equity
37480000
Quarters > 0 > cash Flow > net Income
-6011000
Quarters > 0 > cash Flow > depreciation
148000
Quarters > 0 > cash Flow > change In Working Capital
237000
Quarters > 0 > cash Flow > cash From Operations
-5962000
Quarters > 0 > cash Flow > capital Expenditures
2000
Quarters > 0 > cash Flow > cash From Investing
-2000
Quarters > 0 > cash Flow > cash From Financing
26332000
Quarters > 0 > cash Flow > net Change In Cash
20368000
Quarters > 0 > ratios > PE
-0.3327357080437072
Quarters > 0 > ratios > PB
3.002864820437567
Quarters > 0 > ratios > ROE
-16.037886872998932
Quarters > 0 > ratios > ROA
-11.87686471320464
Quarters > 0 > ratios > FCF
-5964000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
138000
Quarters > 1 > income Statement > gross Profit
-138000
Quarters > 1 > income Statement > operating Expenses
6963000
Quarters > 1 > income Statement > operating Income
-6963000
Quarters > 1 > income Statement > interest Expense
13000
Quarters > 1 > income Statement > pretax Income
-6447000
Quarters > 1 > income Statement > net Income
-6447000
Quarters > 1 > income Statement > eps
-0.5240586149034077
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
12302059
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-6296000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
516000
Quarters > 1 > balance Sheet > cash
22327000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
29526000
Quarters > 1 > balance Sheet > property Plant Equipment
469000
Quarters > 1 > balance Sheet > total Assets
29995000
Quarters > 1 > balance Sheet > payables
708000
Quarters > 1 > balance Sheet > short Term Debt
476000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
13566000
Quarters > 1 > balance Sheet > equity
16429000
Quarters > 1 > cash Flow > net Income
-6447000
Quarters > 1 > cash Flow > depreciation
138000
Quarters > 1 > cash Flow > change In Working Capital
-2308000
Quarters > 1 > cash Flow > cash From Operations
-8420000
Quarters > 1 > cash Flow > capital Expenditures
6000
Quarters > 1 > cash Flow > cash From Investing
-6000
Quarters > 1 > cash Flow > cash From Financing
10984000
Quarters > 1 > cash Flow > net Change In Cash
2558000
Quarters > 1 > ratios > PE
-0.5240586149034077
Quarters > 1 > ratios > PB
4.665033025138475
Quarters > 1 > ratios > ROE
-39.24158500213038
Quarters > 1 > ratios > ROA
-21.493582263710618
Quarters > 1 > ratios > FCF
-8426000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
135000
Quarters > 2 > income Statement > gross Profit
-135000
Quarters > 2 > income Statement > operating Expenses
7989000
Quarters > 2 > income Statement > operating Income
-7989000
Quarters > 2 > income Statement > interest Expense
15000
Quarters > 2 > income Statement > pretax Income
570000
Quarters > 2 > income Statement > net Income
570000
Quarters > 2 > income Statement > eps
0.0460290745637334
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12383477.3
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
720000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
8559000
Quarters > 2 > balance Sheet > cash
19769000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
27346000
Quarters > 2 > balance Sheet > property Plant Equipment
601000
Quarters > 2 > balance Sheet > total Assets
27947000
Quarters > 2 > balance Sheet > payables
1251000
Quarters > 2 > balance Sheet > short Term Debt
694000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
16676000
Quarters > 2 > balance Sheet > equity
11271000
Quarters > 2 > cash Flow > net Income
570000
Quarters > 2 > cash Flow > depreciation
135000
Quarters > 2 > cash Flow > change In Working Capital
-1823000
Quarters > 2 > cash Flow > cash From Operations
-8903000
Quarters > 2 > cash Flow > capital Expenditures
16000
Quarters > 2 > cash Flow > cash From Investing
-16000
Quarters > 2 > cash Flow > cash From Financing
2546000
Quarters > 2 > cash Flow > net Change In Cash
-6373000
Quarters > 2 > ratios > PE
0.0460290745637334
Quarters > 2 > ratios > PB
6.844917361281166
Quarters > 2 > ratios > ROE
5.057226510513708
Quarters > 2 > ratios > ROA
2.0395749096504097
Quarters > 2 > ratios > FCF
-8919000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
568000
Quarters > 3 > income Statement > cost Of Revenue
284000
Quarters > 3 > income Statement > gross Profit
284000
Quarters > 3 > income Statement > operating Expenses
9261000
Quarters > 3 > income Statement > operating Income
-9261000
Quarters > 3 > income Statement > interest Expense
20000
Quarters > 3 > income Statement > pretax Income
-21525000
Quarters > 3 > income Statement > net Income
-21525000
Quarters > 3 > income Statement > eps
-3.21339979803577
Quarters > 3 > income Statement > dividends Per Share
208000
Quarters > 3 > income Statement > shares Outstanding
6698512.9
Quarters > 3 > income Statement > income Tax Expense
-240724
Quarters > 3 > income Statement > EBITDA
-9254000
Quarters > 3 > income Statement > operating Margin
-1630.457746478873
Quarters > 3 > income Statement > total Other Income Expense Net
-12264000
Quarters > 3 > balance Sheet > cash
26142000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
30948000
Quarters > 3 > balance Sheet > property Plant Equipment
720000
Quarters > 3 > balance Sheet > total Assets
31668000
Quarters > 3 > balance Sheet > payables
966000
Quarters > 3 > balance Sheet > short Term Debt
656000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
24237000
Quarters > 3 > balance Sheet > equity
7431000
Quarters > 3 > cash Flow > net Income
-21525000
Quarters > 3 > cash Flow > depreciation
134000
Quarters > 3 > cash Flow > change In Working Capital
1702000
Quarters > 3 > cash Flow > cash From Operations
-6548000
Quarters > 3 > cash Flow > capital Expenditures
22000
Quarters > 3 > cash Flow > cash From Investing
-22000
Quarters > 3 > cash Flow > cash From Financing
365000
Quarters > 3 > cash Flow > net Change In Cash
-6205000
Quarters > 3 > ratios > PE
-3.21339979803577
Quarters > 3 > ratios > PB
5.615897640559818
Quarters > 3 > ratios > ROE
-289.6649172385951
Quarters > 3 > ratios > ROA
-67.9708222811671
Quarters > 3 > ratios > FCF
-6570000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-11.566901408450704
Quarters > 3 > health Score
12
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
428000
Annuals > 0 > income Statement > gross Profit
-428000
Annuals > 0 > income Statement > operating Expenses
32117000
Annuals > 0 > income Statement > operating Income
-32117000
Annuals > 0 > income Statement > interest Expense
71000
Annuals > 0 > income Statement > pretax Income
-36729000
Annuals > 0 > income Statement > net Income
-36729000
Annuals > 0 > income Statement > eps
-5.483157313916645
Annuals > 0 > income Statement > dividends Per Share
1095000
Annuals > 0 > income Statement > shares Outstanding
6698512.9
Annuals > 0 > income Statement > income Tax Expense
-1095000
Annuals > 0 > income Statement > EBITDA
-36230000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-4612000
Annuals > 0 > balance Sheet > cash
26142000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
30948000
Annuals > 0 > balance Sheet > property Plant Equipment
720000
Annuals > 0 > balance Sheet > total Assets
31668000
Annuals > 0 > balance Sheet > payables
966000
Annuals > 0 > balance Sheet > short Term Debt
656000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
24237000
Annuals > 0 > balance Sheet > equity
7431000
Annuals > 0 > cash Flow > net Income
-36729000
Annuals > 0 > cash Flow > depreciation
428000
Annuals > 0 > cash Flow > change In Working Capital
-427000
Annuals > 0 > cash Flow > cash From Operations
-28575000
Annuals > 0 > cash Flow > capital Expenditures
72000
Annuals > 0 > cash Flow > cash From Investing
-72000
Annuals > 0 > cash Flow > cash From Financing
45088000
Annuals > 0 > cash Flow > net Change In Cash
16441000
Annuals > 0 > ratios > PE
-5.483157313916645
Annuals > 0 > ratios > PB
5.606883358632755
Annuals > 0 > ratios > ROE
-494.26725878078315
Annuals > 0 > ratios > ROA
-115.9814323607427
Annuals > 0 > ratios > FCF
-28647000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
11
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
675000
Annuals > 1 > income Statement > cost Of Revenue
284000
Annuals > 1 > income Statement > gross Profit
675000
Annuals > 1 > income Statement > operating Expenses
21449000
Annuals > 1 > income Statement > operating Income
-20774000
Annuals > 1 > income Statement > interest Expense
82000
Annuals > 1 > income Statement > pretax Income
-30544000
Annuals > 1 > income Statement > net Income
-30544000
Annuals > 1 > income Statement > eps
-12.446967742776794
Annuals > 1 > income Statement > dividends Per Share
867000
Annuals > 1 > income Statement > shares Outstanding
2453931
Annuals > 1 > income Statement > income Tax Expense
116105
Annuals > 1 > income Statement > EBITDA
-30178000
Annuals > 1 > income Statement > operating Margin
-3077.62962962963
Annuals > 1 > income Statement > total Other Income Expense Net
-9770000
Annuals > 1 > balance Sheet > cash
9701000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
13399000
Annuals > 1 > balance Sheet > property Plant Equipment
792000
Annuals > 1 > balance Sheet > total Assets
14191000
Annuals > 1 > balance Sheet > payables
821000
Annuals > 1 > balance Sheet > short Term Debt
345000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
18000000
Annuals > 1 > balance Sheet > equity
-3809000
Annuals > 1 > cash Flow > net Income
-30544000
Annuals > 1 > cash Flow > depreciation
284000
Annuals > 1 > cash Flow > change In Working Capital
-93000
Annuals > 1 > cash Flow > cash From Operations
-18283000
Annuals > 1 > cash Flow > capital Expenditures
12000
Annuals > 1 > cash Flow > cash From Investing
-12000
Annuals > 1 > cash Flow > cash From Financing
27541000
Annuals > 1 > cash Flow > net Change In Cash
9246000
Annuals > 1 > ratios > PE
-12.446967742776794
Annuals > 1 > ratios > PB
-4.007206831189288
Annuals > 1 > ratios > ROE
801.8902599107378
Annuals > 1 > ratios > ROA
-215.23500810372772
Annuals > 1 > ratios > FCF
-18295000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-27.103703703703705
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
951000
Annuals > 2 > income Statement > cost Of Revenue
7000
Annuals > 2 > income Statement > gross Profit
951000
Annuals > 2 > income Statement > operating Expenses
19003000
Annuals > 2 > income Statement > operating Income
-18052000
Annuals > 2 > income Statement > interest Expense
6000
Annuals > 2 > income Statement > pretax Income
-18058000
Annuals > 2 > income Statement > net Income
-18064000
Annuals > 2 > income Statement > eps
-11.997037932397117
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1505705
Annuals > 2 > income Statement > income Tax Expense
6000
Annuals > 2 > income Statement > EBITDA
-17891000
Annuals > 2 > income Statement > operating Margin
-1898.2124079915877
Annuals > 2 > income Statement > total Other Income Expense Net
-6000
Annuals > 2 > balance Sheet > cash
455000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2644000
Annuals > 2 > balance Sheet > property Plant Equipment
174000
Annuals > 2 > balance Sheet > total Assets
2818000
Annuals > 2 > balance Sheet > payables
846000
Annuals > 2 > balance Sheet > short Term Debt
201000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3284000
Annuals > 2 > balance Sheet > equity
-466000
Annuals > 2 > cash Flow > net Income
-18058000
Annuals > 2 > cash Flow > depreciation
161000
Annuals > 2 > cash Flow > change In Working Capital
1178000
Annuals > 2 > cash Flow > cash From Operations
-15651000
Annuals > 2 > cash Flow > capital Expenditures
2000
Annuals > 2 > cash Flow > cash From Investing
-2000
Annuals > 2 > cash Flow > cash From Financing
-471000
Annuals > 2 > cash Flow > net Change In Cash
-16124000
Annuals > 2 > ratios > PE
-11.997037932397117
Annuals > 2 > ratios > PB
-20.097607510729613
Annuals > 2 > ratios > ROE
3876.394849785408
Annuals > 2 > ratios > ROA
-641.0220014194464
Annuals > 2 > ratios > FCF
-15653000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-16.45951629863302
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1000
Annuals > 3 > income Statement > gross Profit
-1000
Annuals > 3 > income Statement > operating Expenses
8977000
Annuals > 3 > income Statement > operating Income
-8977000
Annuals > 3 > income Statement > interest Expense
628000
Annuals > 3 > income Statement > pretax Income
-10017000
Annuals > 3 > income Statement > net Income
-10632000
Annuals > 3 > income Statement > eps
-9.106053144337622
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1167575
Annuals > 3 > income Statement > income Tax Expense
615000
Annuals > 3 > income Statement > EBITDA
-8964000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1040000
Annuals > 3 > balance Sheet > cash
16579000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
18411000
Annuals > 3 > balance Sheet > property Plant Equipment
333000
Annuals > 3 > balance Sheet > total Assets
18744000
Annuals > 3 > balance Sheet > payables
742000
Annuals > 3 > balance Sheet > short Term Debt
180000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2260000
Annuals > 3 > balance Sheet > equity
16484000
Annuals > 3 > cash Flow > net Income
-10017000
Annuals > 3 > cash Flow > depreciation
13000
Annuals > 3 > cash Flow > change In Working Capital
-105000
Annuals > 3 > cash Flow > cash From Operations
-5767000
Annuals > 3 > cash Flow > capital Expenditures
29000
Annuals > 3 > cash Flow > cash From Investing
-29000
Annuals > 3 > cash Flow > cash From Financing
22375000
Annuals > 3 > cash Flow > net Change In Cash
16579000
Annuals > 3 > ratios > PE
-9.106053144337622
Annuals > 3 > ratios > PB
0.44056761101674347
Annuals > 3 > ratios > ROE
-64.49890803203107
Annuals > 3 > ratios > ROA
-56.72215108834827
Annuals > 3 > ratios > FCF
-5796000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.3327357080437072
Valuation > metrics > PB
3.002864820437567
Valuation > final Score
49.97135179562433
Valuation > verdict
0.1% Overvalued
Profitability > metrics > ROE
-16.037886872998932
Profitability > metrics > ROA
-11.95338755543182
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3503468516542156
Risk > metrics > Interest Coverage
-489.46666666666664
Risk > final Score
-1898
Risk > verdict
High
Liquidity > metrics > Current Ratio
41.15139116202946
Liquidity > metrics > Quick Ratio
41.15139116202946
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
33.349669748615256
Prev Valuations > 1
40
Prev Valuations > 2
23.84102359440182
Prev Profitabilities > 0
15
Prev Profitabilities > 1
31
Prev Profitabilities > 2
0
Prev Risks > 0
-2094
Prev Risks > 1
-2100
Prev Risks > 2
-1846
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:21:46.552Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.33
Earnings History > 0 > eps Estimate
-0.0662
Earnings History > 0 > eps Difference
-0.2638
Earnings History > 0 > surprise Percent
-398.4894
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.52
Earnings History > 1 > eps Estimate
-0.07
Earnings History > 1 > eps Difference
-0.45
Earnings History > 1 > surprise Percent
-642.8571
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.5
Earnings History > 2 > eps Estimate
-0.1
Earnings History > 2 > eps Difference
-0.4
Earnings History > 2 > surprise Percent
-400
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.25
Earnings History > 3 > eps Estimate
-0.0914
Earnings History > 3 > eps Difference
0.3414
Earnings History > 3 > surprise Percent
373.523
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.05
Earnings History > 4 > eps Estimate
-0.15
Earnings History > 4 > eps Difference
0.1
Earnings History > 4 > surprise Percent
66.6667
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-14
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.29
Earnings History > 5 > eps Estimate
-0.2
Earnings History > 5 > eps Difference
-0.09
Earnings History > 5 > surprise Percent
-45
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.61
Earnings History > 6 > eps Estimate
-0.15
Earnings History > 6 > eps Difference
-0.46
Earnings History > 6 > surprise Percent
-306.6667
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.22
Earnings History > 7 > eps Estimate
-0.17
Earnings History > 7 > eps Difference
-0.05
Earnings History > 7 > surprise Percent
-29.4118
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.13
Earnings History > 8 > eps Estimate
-0.12
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-8.3333
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.29
Earnings History > 9 > eps Estimate
-0.34
Earnings History > 9 > eps Difference
0.05
Earnings History > 9 > surprise Percent
14.7059
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-16
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.28
Earnings History > 10 > eps Estimate
-0.37
Earnings History > 10 > eps Difference
0.09
Earnings History > 10 > surprise Percent
24.3243
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.35
Earnings History > 11 > eps Estimate
-0.24
Earnings History > 11 > eps Difference
-0.11
Earnings History > 11 > surprise Percent
-45.8333
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.37
Earnings History > 12 > eps Estimate
-0.28
Earnings History > 12 > eps Difference
-0.09
Earnings History > 12 > surprise Percent
-32.1429
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.24
Earnings History > 13 > eps Estimate
-0.23
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-4.3478
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.24
Earnings History > 14 > eps Estimate
-0.16
Earnings History > 14 > eps Difference
-0.08
Earnings History > 14 > surprise Percent
-50
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.24
Earnings History > 15 > eps Estimate
-0.13
Earnings History > 15 > eps Difference
-0.11
Earnings History > 15 > surprise Percent
-84.6154
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-11
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.08
Earnings History > 16 > eps Estimate
-0.1
Earnings History > 16 > eps Difference
0.02
Earnings History > 16 > surprise Percent
20
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-16
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.13
Earnings History > 17 > eps Estimate
-0.11
Earnings History > 17 > eps Difference
-0.02
Earnings History > 17 > surprise Percent
-18.1818
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-21
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.07
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.07
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-09-30
Earnings History > 19 > report Date
2020-11-02
Earnings History > 19 > date
2020-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.06
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.06
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-06-30
Earnings History > 20 > report Date
2020-09-15
Earnings History > 20 > date
2020-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.03
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.03
Earnings History > 20 > surprise Percent
-
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb RZB 012 for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company also evaluates licensing of technologies and drugs for orphan diseases, other renal, liver, and other metabolic diseases affecting fibrosis and inflammation. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd to develop and commercialize oxylanthanum carbonate; Sphaera Pharma Pte. Ltd.; Syneos Health LLC to develop of UNI-494; Inotiv for preclinical trial and related services for oxylanthanum carbonate and UNI-494; Lee's Pharmaceutical (HK) Limited; and Lotus International Pte Ltd for the development, registration filing, and approval for oxylanthanum carbonate. The company was incorporated in 2016 and is based in Los Altos, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AUnicycive stock price target lowered to $63 by Lucid Capital Markets - Investing.com Nigeria
12/11/2025
Unicycive stock price target lowered to $63 by Lucid Capital Markets Investing.com Nigeria
Read more →Vivo Capital LLC Has $5.42 Million Stock Position in Unicycive Therapeutics, Inc. $UNCY - MarketBeat
12/9/2025
Vivo Capital LLC Has $5.42 Million Stock Position in Unicycive Therapeutics, Inc. $UNCY MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$46.5238
Analyst Picks
Strong Buy
4
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 32.86% of the total shares of Unicycive Therapeutics Inc
1.
Vivo Capital, LLC(6.4377%)
since
2025/06/30
2.
Octagon Capital Advisors LP(5.662%)
since
2025/06/30
3.
Nantahala Capital Management, LLC(5.3177%)
since
2025/06/30
4.
Great Point Partners LLC(4.5101%)
since
2025/06/30
5.
Vanguard Group Inc(3.4309%)
since
2025/06/30
6.
Logos Global Management LP(2.6813%)
since
2025/06/30
7.
Vanguard Total Stock Mkt Idx Inv(2.6582%)
since
2025/07/31
8.
Vanguard Institutional Extnd Mkt Idx Tr(0.4624%)
since
2025/07/31
9.
Longwood Capital Partners LLC(0.3561%)
since
2025/06/30
10.
Geode Capital Management, LLC(0.3328%)
since
2025/06/30
11.
Fidelity Extended Market Index(0.2008%)
since
2025/07/31
12.
JPMorgan Chase & Co(0.1229%)
since
2025/06/30
13.
State Street Corp(0.0709%)
since
2025/06/30
14.
Renaissance Technologies Corp(0.0668%)
since
2025/06/30
15.
Lazard Asset Management LLC(0.0655%)
since
2025/06/30
16.
Fidelity Total Market Index(0.0616%)
since
2025/07/31
17.
Northern Trust Corp(0.0611%)
since
2025/06/30
18.
Fidelity Series Total Market Index(0.054%)
since
2025/07/31
19.
Goldman Sachs Group Inc(0.0416%)
since
2025/03/31
20.
Vanguard Instl Ttl Stk Mkt Idx InstlPls(0.0415%)
since
2025/07/31
21.
Spartan Extended Market Index Pool F(0.0365%)
since
2025/07/31
22.
Northern Trust Extended Eq Market Idx(0.032%)
since
2025/06/30
23.
NT Ext Equity Mkt Idx Fd - L(0.032%)
since
2025/06/30
24.
NT Ext Equity Mkt Idx Fd - NL(0.0281%)
since
2025/06/30
25.
Fidelity Nasdaq Composite Index(0.024%)
since
2025/07/31
26.
Spartan Total Market Index Pool G(0.0233%)
since
2025/07/31
27.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0218%)
since
2025/06/30
28.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.009%)
since
2025/06/30
29.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0076%)
since
2024/12/31
30.
Morgan Stanley - Brokerage Accounts(0.0057%)
since
2025/06/30
31.
SBI Securities Co Ltd(0.0031%)
since
2025/06/30
32.
State St US Extended Mkt Indx NL Cl C(0.0012%)
since
2025/08/31
33.
Northern Trust Wilshire 5000(0.0009%)
since
2025/06/30
34.
HARBOUR INVESTMENTS, INC.(0.0006%)
since
2025/06/30
35.
Barclays PLC(0.0005%)
since
2025/06/30
36.
SSgA U.S. Total Market Index Strategy(0.0005%)
since
2025/03/31
37.
Bank of America Corp(0.0004%)
since
2025/06/30
38.
Bogart Wealth, LLC(0%)
since
2025/06/30
39.
1290 VT Micro Cap K(0%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.33
EPS Estimate
-0.0662
EPS Difference
-0.2638
Surprise Percent
-398.4894%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.